Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1Classical hematology 1

Conditions

Stomach Neoplasms 140Esophageal Neoplasms 71Pancreatic Neoplasms 42Esophageal Squamous Cell Carcinoma 26Carcinoma, Non-Small-Cell Lung 24Adenocarcinoma Of Esophagus 23Breast Neoplasms 18Neoplasms 15Neoplasm Metastasis 15Colorectal Neoplasms 15Prostatic Neoplasms 11Ovarian Neoplasms 9Melanoma 9Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Adenocarcinoma 8Sarcoma 7Colonic Neoplasms 7Biliary Tract Neoplasms 7Small Cell Lung Carcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Rectal Neoplasms 4Head and Neck Neoplasms 4

Interventions

Drug Therapy 3Radiotherapy 2uridine triacetate 1camrelizumab 1bismuth tripotassium dicitrate 1Telbivudine 1Tegafur 1Surgical Procedures, Operative 1Pharmaceutical Services 1Ofloxacin 1Octreotide 1Metronidazole 1Levofloxacin 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Esomeprazole 1Docetaxel 1Dihydrouracil Dehydrogenase (NADP) 1Clarithromycin 1Cisplatin 1Celecoxib 1Capecitabine 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Docetaxel × Gastrointestinal × Clear all
NCT05800054 2023-04-05

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
210 enrolled
Gastrointestinal

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡